RhythmAnalytics vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Viz.ai

AI Verdict

RhythmAnalytics specializes in the automated interpretation of a wide range of cardiac arrhythmias from ECG data, offering broad clinical decision support. Viz HCM, however, is specifically designed for real-time AI-powered detection of Hypertrophic Cardiomyopathy (HCM) from ECGs, integrating intelligent care coordination. While both utilize AI for cardiac ECG analysis and clinical decision support, their distinct focus on either general arrhythmias or a specific cardiac condition makes them adjacent rather than direct competitors.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is comprehensive, AI-powered automated interpretation of a wide range of cardiac arrhythmias from various single-lead ECG sources. This tool is ideal for healthcare professionals requiring clinical decision support across more than 15 types of rhythm disorders, leveraging its cloud-based API for integration with diverse ECG monitoring devices.

View RhythmAnalytics →

Choose Viz HCM if…

Choose Viz HCM if your focus is specifically on accelerating the detection and care coordination for Hypertrophic Cardiomyopathy (HCM) patients. This AI tool excels at real-time ECG analysis for suspected HCM, providing immediate alerts to multidisciplinary teams and streamlining patient pathways to appropriate specialists, thereby significantly reducing diagnosis time for this specific condition.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics Viz HCM
Pricing Contact vendor Subscription-based
Deployment Cloud-based API Cloud-based platform, integrated into hospital IT systems (EHR, PACS).
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Tool B (Viz HCM) explicitly mentions 'Mobile-based alerts and notifications to multidisciplinary care teams' and 'Seamless integration with existing clinical workflows, EHR, and PACS systems,' suggesting a direct and user-friendly experience for clinicians. In contrast, Tool A (RhythmAnalytics) is described as a 'Cloud-based API for integration,' indicating it's primarily a backend service for developers rather than a direct end-user application.

Clinical Value

Viz HCM

While Tool A (RhythmAnalytics) offers broad detection of over 15 types of cardiac arrhythmias, Tool B (Viz HCM) focuses on a critical condition, Hypertrophic Cardiomyopathy (HCM), with explicit claims of 'significantly reducing diagnosis time' and 'streamlines cardiac care coordination.' Its emphasis on automated patient direction to specialists and extensive clinical validation suggests a more comprehensive and impactful clinical solution beyond just detection.

Pricing & Value

Viz HCM

Tool B (Viz HCM) offers greater transparency by stating it is 'subscription-based' and explicitly mentioning CMS reimbursement available for specific CPT codes, providing a clear financial value proposition for healthcare providers. Tool A (RhythmAnalytics) only states 'contact vendor' for pricing and has an 'unspecified' BAA, making its cost and value less transparent.

Enterprise Readiness

Viz HCM

Both tools are FDA-cleared and HIPAA compliant. However, Tool B (Viz HCM) explicitly confirms it 'has_baa: yes' and offers 'Seamless integration with existing clinical workflows, EHR, and PACS systems,' demonstrating a more robust and proven readiness for enterprise deployment. Tool A's BAA status is unspecified, and its integration is described as a 'Cloud-based API,' which may require more custom development.

Innovation

Viz HCM

While both tools leverage AI for ECG analysis, Tool B (Viz HCM) demonstrates greater innovation by extending beyond mere disease detection to include 'intelligent care coordination' and 'Automated direction of patients to appropriate care specialists.' This comprehensive approach to patient management and workflow optimization goes beyond the advanced arrhythmia detection offered by Tool A (RhythmAnalytics).

Support & Docs

Tie

Neither the provided structured facts nor general web searches yield specific, comparative information regarding the level of customer support or the availability and quality of documentation for either RhythmAnalytics or Viz HCM. Without this data, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics Viz HCM
Name RhythmAnalytics Viz HCM
Company Biofourmis Singapore Pte. Viz.ai
Primary Function AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data AI tool for real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care
Key Differentiator (Arrhythmia/Condition Detection) Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection
Integration Capabilities Cloud-based API for integration; Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors) Seamless integration with existing clinical workflows, EHR, and PACS systems

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics by Biofourmis is designed for the automated interpretation of over 15 types of cardiac arrhythmias from single-lead ECG data, providing broad clinical decision support. In contrast, Viz HCM by Viz.ai specifically focuses on the real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) from ECGs and coordinating cardiac care.
RhythmAnalytics offers a cloud-based API for integration and is compatible with various FDA-cleared ECG devices, including Holter monitors, event recorders, and wearable sensors. Viz HCM is a cloud-based platform engineered for seamless integration with existing hospital IT systems, such as EHR and PACS, and provides mobile-based alerts to care teams.
RhythmAnalytics is designed to process single-lead ECG data from compatible FDA-cleared ECG devices. Viz HCM analyzes 12-lead ECGs, often in real-time, from across the health system to identify patterns suggestive of HCM.
Viz HCM has established CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90, effective January 1, 2025. The provided information for RhythmAnalytics does not specify any direct reimbursement pathways.
RhythmAnalytics provides automated interpretation of cardiac arrhythmias and clinical decision support for healthcare professionals. Viz HCM extends beyond detection by offering mobile-based alerts and notifications to multidisciplinary care teams, automating the direction of patients to appropriate specialists, and streamlining cardiac care coordination to reduce diagnosis time for HCM.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.